Page last updated: 2024-10-25

chlorpropamide and Cataract

chlorpropamide has been researched along with Cataract in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leslie, RD1
Barnett, AH1
Pyke, DA1

Other Studies

1 other study available for chlorpropamide and Cataract

ArticleYear
Chlorpropamide alcohol flushing and diabetic retinopathy.
    Lancet (London, England), 1979, May-12, Volume: 1, Issue:8124

    Topics: Cataract; Chlorpropamide; Diabetic Retinopathy; Dilatation, Pathologic; Ethanol; Face; Humans; Vasod

1979